vapreotide [8621]



vapreotide


SMILES CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2ccccc2)CSSCC(C(=O)NC(Cc2c[nH]c3ccccc23)C(N)=O)NC1=O
InChIKey SWXOGPJRIDTIRL-UHFFFAOYSA-N
Sequence FCYWKVCW
HELM PEPTIDE1{(F,[dF]).(C,[dC]).(Y,[dY]).(W,[dW]).(K,[dK]).(V,[dV]).(C,[dC]).(W,[dW]).[am]}$PEPTIDE1,PEPTIDE1,2:R3-7:R3$$$V2.0

Chemical Properties

Hydrogen bond acceptors 13
Hydrogen bond donors 13
Rotatable bonds 18
Log P 2.012
Molecular weight (Da) 1130.5
Stereochemistry info unspecified


No bioactivity data available.

vapreotide


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.